FCM
IDXX icon

Frontier Capital Management’s Idexx Laboratories IDXX Stock Holding History

Frontier Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.9M Sell
35,364
-9,979
-22% -$6.4M 0.2% 166
2025
Q4 		$30.7M Sell
45,343
-62,959
-58% -$42.9M 0.33% 112
2025
Q3 		$69.2M Sell
108,302
-763
-0.7% -$463K 0.62% 39
2025
Q2 		$58.5M Sell
109,065
-6,851
-6% -$3.28M 0.54% 57
2025
Q1 		$48.7M Buy
115,916
+25,787
+29% +$11.2M 0.53% 61
2024
Q4 		$37.3M Sell
90,129
-50,466
-36% -$22.1M 0.35% 111
2024
Q3 		$71M Sell
140,595
-3,692
-3% -$1.79M 0.67% 40
2024
Q2 		$70.3M Sell
144,287
-6,795
-4% -$3.41M 0.7% 31
2024
Q1 		$81.6M Sell
151,082
-4,618
-3% -$2.52M 0.76% 31
2023
Q4 		$86.4M Sell
155,700
-3,314
-2% -$1.56M 0.87% 26
2023
Q3 		$69.5M Sell
159,014
-1,298
-0.8% -$647K 0.76% 30
2023
Q2 		$80.5M Buy
160,312
+4,514
+3% +$2.16M 0.77% 36
2023
Q1 		$77.9M Buy
155,798
+43,042
+38% +$20.6M 0.81% 37
2022
Q4 		$46M Sell
112,756
-3,788
-3% -$1.47M 0.5% 67
2022
Q3 		$38M Sell
116,544
-6,096
-5% -$2.24M 0.45% 72
2022
Q2 		$43M Buy
122,640
+11,497
+10% +$4.69M 0.5% 68
2022
Q1 		$60.8M Sell
111,143
-17,492
-14% -$9.2M 0.55% 55
2021
Q4 		$84.7M Sell
128,635
-19,036
-13% -$11.9M 0.67% 42
2021
Q3 		$91.8M Sell
147,671
-11,815
-7% -$7.94M 0.72% 36
2021
Q2 		$101M Sell
159,486
-20,518
-11% -$11.3M 0.74% 34
2021
Q1 		$88.1M Sell
180,004
-37,370
-17% -$18.7M 0.67% 42
2020
Q4 		$109M Buy
217,374
+23,443
+12% +$10.5M 0.8% 32
2020
Q3 		$76.2M Sell
193,931
-14,960
-7% -$5.53M 0.67% 43
2020
Q2 		$69M Buy
208,891
+48,373
+30% +$14M 0.61% 52
2020
Q1 		$38.9M Sell
160,518
-24,318
-13% -$6.35M 0.44% 80
2019
Q4 		$48.3M Sell
184,836
-48,266
-21% -$12.7M 0.36% 105
2019
Q3 		$63.4M Buy
233,102
+46,990
+25% +$13.1M 0.5% 70
2019
Q2 		$51.2M Sell
186,112
-5,337
-3% -$1.31M 0.39% 102
2019
Q1 		$42.8M Buy
+191,449
New +$39.5M 0.3% 131

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Frontier Capital Management's IDXX Position: Q1 2026 in Review

Frontier Capital Management reduced its Idexx Laboratories (IDXX) stake by 22% in Q1 2026, selling an estimated $6.4M and leaving 35,364 shares worth $19.9M. The position accounts for 0.2% of the portfolio, ranked #166.

Frontier Capital Management first reported a position in IDXX in Q1 2019 and has held it in 29 quarters since. The position peaked at $109M in Q4 2020. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Frontier Capital Management held 35,364 shares of Idexx Laboratories worth $19.9M as of Q1 2026.
  • Frontier Capital Management sold 9,979 Idexx Laboratories shares in Q1 2026, an estimated $6.4M.
  • Idexx Laboratories made up 0.2% of Frontier Capital Management's portfolio in Q1 2026, its #166 holding.
  • Frontier Capital Management first reported a position in Idexx Laboratories in Q1 2019 and has held it in 29 quarters since.
  • Frontier Capital Management's Idexx Laboratories position peaked at $109M in Q4 2020.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Frontier Capital Management's 13F filing for Q1 2026, filed 15 May 2026.